A global trial reveals tirzepatide helps people lose more weight faster than semaglutide. This breakthrough could change obesity treatment options in India and beyond.

Results were promising, with those taking 5-mg, 10-mg, and 15-mg weekly injections of tirzepatide losing weight, and those on the highest dose losing 22.9 percent of their body weight on average.

But while semaglutide mimics just GLP-1, tirzepatide also mimics an additional hormone, GIP. That dual action may give the drug a bit ... 12 and 20 percent of their body weight, on average.

BOSTON, MA—Tirzepatide improves outcomes in patients with heart failure with preserved ejection fraction (HFpEF) and obesity, no matter how much excess body weight they have ... indicated that she ...

In this analysis, body weight changes were evaluated in participants who had received at least one dose of tirzepatide (5, 10, or 15 mg) or placebo. The study used a mixed model to assess ...

The SURMOUNT-5 trial, published over the weekend in the New England Journal of Medicine and presented at the European Congress on Obesity, showed that treatment with tirzepatide (Zepbound; Eli Lilly) ...

Tirzepatide discontinuation was associated with reduced cardiometabolic benefits especially among patients with body weight regain.

In an earlier analysis of the SURMOUNT-1 trial, tirzepatide was shown to provide substantial and sustained reductions in body weight in persons with obesity over a 72-week period. Here ...

Incident cardiovascular death or worsening heart failure (HF) events were down over a median 104 weeks of follow-up in people who had been randomized to tirzepatide (Zepbound, Mounjaro ...

Messer: In terms of outcomes, the weight loss is almost double [with tirzepatide]. It depends what trial you’re looking at, but we tend to see like about 15% of your body weight you lose with ...

Share on Pinterest Researchers have compared the effectiveness of weight loss medications such as tirzepatide and semaglutide ... They looked at the changes in body weight that participants ...

Both medications were effective: The vast majority of people using either tirzepatide or semaglutide lost at least 5% of their starting body weight after one year of use. But 82% of people taking ...